Skoda-Smith, S <br/><br/>
Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab.  [electronic resource] 

 -  Bone marrow transplantation  Feb 2001 
 - 329-32 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702792  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child, Preschool<br/>Disease-Free Survival<br/>Haplotypes--immunology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Lymphoma, B-Cell--etiology<br/>Lymphoproliferative Disorders--etiology<br/>Major Histocompatibility Complex--genetics<br/>Male<br/>Remission Induction<br/>Rituximab<br/>Severe Combined Immunodeficiency--complications